Letter by Zhang et al Regarding Article, “Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with great interest the recent article by Fauchier et al,1 in which the authors observed a positive net clinical benefit of oral anticoagulation usage for preventing stroke and other thromboembolic events in atrial fibrillation patients with only 1 nongender-related …